CVRx, Inc. Launches HOPE4HF™ Clinical Trial Evaluating Barostim Neo™ in Heart Failure Patients
4/29/2013 9:52:05 AM
More...
|
CVRx, Inc. Tracks Hypertension-treating Heart Implants With Euro Registry
7/3/2012 9:25:10 AM
More...
|
ON Semiconductor Selected by CVRx, Inc. for Advanced Implantable Device Used in the Treatment of Hypertension
5/21/2012 10:15:24 AM
More...
|
CVRx, Inc. Receives CE Mark Approval and Introduces New Implantable Device for Hypertension, the Barostim neo(TM)
8/25/2011 6:51:15 AM
More...
|
CVRx, Inc. Release: Four-Year Clinical Study Findings Show Significant and Persistent Reduction in Blood Pressure with Rheos(R) System
6/21/2010 9:46:22 AM
More...
|
New CVRx, Inc. Heart Device May Do Double Duty
1/8/2010 8:03:26 AM
More...
|
CVRx, Inc. Enrolls First Patient in HOPE4HF(TM) Clinical Trial
10/1/2009 9:27:13 AM
More...
|
Longer-Term Clinical Trial Findings Show Significant Reduction in Blood Pressure, Improvement in Heart Function with CVRx, Inc. Rheos(R) System
3/30/2009 9:45:04 AM
More...
|
Clinical Data Presented at American Heart Association Meeting Show CVRx, Inc. Rheos(R) Therapy Improved Heart Structure and Function
11/11/2008 1:53:02 PM
More...
|
Clinical Data Show CVRx, Inc.(R) Rheos(R) Therapy Improved Heart Structure and Function in Early-Stage Heart Failure Patients
9/23/2008 9:43:09 AM
More...
|
|